Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Very strange , even for ONC

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Feb 27, 2024 12:35pm

95 Views

Post# 35901689

RE:RE:RE:RE:RE:RE:RE:Very strange , even for ONC

So to sum it up... canuckfan knows absolutely jack dung about anything here. Wished these pumpers would just shut up. They have shown for numerous years that their crystal ball is severely cracked

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season